Next Article in Journal
Availability of Using Honeybees and Hive Products as Bioindicators of Ambient Pesticide Exposure in Taiwan
Next Article in Special Issue
Integrated Biomarker Response Emphasizing Neuronal Oxidative Stress and Genotoxicity Induced by Oxamyl in Sprague Dawley Rats: Ameliorative Effect of Ginseng as a Neuroprotective Agent
Previous Article in Journal
The Fibrotic Phenotype of Human Precision-Cut Lung Slices Is Maintained after Cryopreservation
Previous Article in Special Issue
Role of IRE1α/XBP1/CHOP/NLRP3 Signalling Pathway in Neonicotinoid Imidacloprid-Induced Pancreatic Dysfunction in Rats and Antagonism of Lycopene: In Vivo and Molecular Docking Simulation Approaches
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxics
Volume 12
Issue 9
10.3390/toxics12090638
toxics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Fungicide Ipconazole Can Activate Mediators of Cellular Damage in Rat Brain Regions

by
Carlos Villaorduña
1,
Luis Barrios-Arpi
1,
Boris Lira-Mejía
1,
Mariella Ramos-Gonzalez
2,
Olger Ramos-Coaguila
2,
Luis Inostroza-Ruiz
3,
Alejandro Romero
4 and
José-Luis Rodríguez
1,4,*
1
Animal Physiology Laboratory, Faculty of Veterinary Medicine, Major National University of San Marcos, Lima 15021, Peru
2
Zootecnia an Animal Production Laboratory, Faculty of Veterinary Medicine, Major National University of San Marcos, Lima 15021, Peru
3
Toxicology Laboratory, Faculty of Pharmacy and Biochemistry, Major National University of San Marcos, Lima 15021, Peru
4
Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Toxics 2024, 12(9), 638; https://doi.org/10.3390/toxics12090638
Submission received: 13 August 2024 / Revised: 29 August 2024 / Accepted: 29 August 2024 / Published: 31 August 2024
(This article belongs to the Special Issue Drug and Pesticides-Induced Oxidative Stress and Apoptosis)
Browse Figures
Versions Notes

Abstract

:
This study aimed to investigate the toxicity of the fungicide ipconazole on oxidative status, cell death and inflammasome complex activation in the hypothalamus, cerebral cortex, striatum and hippocampus of rats. Female albino rats were randomly divided into a control group and four groups treated with ipconazole at doses of 1, 5, 10 and 20 mg/kg b.w., administered for six days. Ipconazole significantly increased MDA and ROS levels in all brain regions studied, while reducing catalase enzyme activity. The molecular expression of cell death-related genes (AKT1, APAF1, BNIP3, CASP3 and BAX) and the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFĸB and TNFα) was also assessed, showing increased expression in at least one brain region. The findings demonstrate that ipconazole induces central nervous system toxicity in mammals, highlighting its potential role as a risk factor in the development of neurodegenerative disorders in individuals exposed to this contaminant.

1. Introduction

Agrochemical pesticides are widely used to control pests affecting crops, with their usage increasing every year [1]. Among the most commonly used pesticides in agriculture are fungicides, which are compounds that target fungi affecting crops. These fungicides can enter ecosystems as contaminants through various pathways, producing toxic effects on a wide variety of non-target organisms [2].
One of the most widely used classes of agricultural fungicides worldwide is the triazoles. These fungicides are now recognized as environmental contaminants in both aquatic and terrestrial environments, even reaching drinking water [3]. The physicochemical properties of agricultural triazoles indicate that they have a low molecular weight and are moderately lipophilic, allowing them to accumulate on organic surfaces [2,4]. This accumulation over long periods results in continuous low-dose exposure for animals and humans, negatively impacting ecosystems and the health of living organisms within them [5].
Several in vivo and in vitro studies have reported the toxicity of triazoles in non-target organisms [6,7,8,9,10,11,12,13,14,15,16,17,18,19]. For example, the triazole propiconazole has been shown in vivo to alter reproductive physiology, hepatic CYP enzyme activity, antioxidant enzyme activity and hypothalamic–pituitary–thyroid axis activity [6,7,8,9]. In vitro studies have demonstrated that it can induce inflammation in liver cells [10]. Additionally, penconazole has been found to inhibit antioxidant enzymes and alter nervous system development [11,12]. The triazole tebuconazole causes gene toxicity, reproductive and sensorimotor impairment, and oxidative stress, among other toxic effects, in both in vivo and in vitro studies [13,14,15,16]. The triazole ipconazole, the subject of the present study, has not been widely reported as toxic, but it has been shown to reduce sensorimotor activity and cause toxicity in neuronal and endothelial cells [17,18,19].
Ipconazole is an agricultural pesticide that acts by inhibiting ergosterol biosynthesis in fungi and was synthesized in 1986 especially for use on rice seeds [20]. Currently, ipconazole is used to control a number of diseases caused by various fungi, such as Rhizoctonia solani, Fusarium fujikuroi and F. oxysporum, in more than 50 crops, including maize, cotton and cereals. However, misuse and abuse of this fungicide is leading to resistance in target pathogens [21] or levels that exceed maximum residue limits (MRLs) [22] and could cause health problems in operators, consumers, production animals and other non-target organisms [23]. The Commission of the European Union has revoked the marketing of ipconazole as a plant protection active substance because it presents a high long-term risk to birds and is classified as a category 1B reproductive toxicant, and also because of uncertainty about its toxicity to humans [24].
The toxicity induced by the fungicide ipconazole in non-target organisms, including humans, is a latent concern that needs to be addressed. For this reason, the present study developed several assays (ROS production, MDA levels, catalase activity and molecular assays) to evaluate ipconazole fungicide-induced toxicity in four brain regions (hypothalamus, cerebral cortex, striatum and hippocampus) of rats.

2. Materials and Methods

2.1. Chemicals

Antibiotics (gentamicin, streptomycin and penicillin G); fluorescent probes 4-amino-5-methylamino-2,7-difluorofluorescein-diacetate (DAF-FM-DA) and 2′,7′-dichlorofluorescin-diacetate (DCFH-DA); Dulbecco’s phosphate buffered saline; Dimethyl sulfoxide; and 4,6-Dihydroxy-2-mercaptopyrimidine were obtained from Sigma-Aldrich (Saint Louis, MO, USA). For molecular assay, NucleoSpin RNA-extraction, the kit for cDNA synthesis and MasterMix ICgreen were obtained from Cultek (Madrid, Spain). The catalase colorimetric activity assay kit was obtained from Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA). All other chemicals were obtained from the usual commercial sources and were of the highest grade available.

2.2. Animals and Experimental Design

The study was conducted in accordance with the requirements of the Bioethics Committee of the Universidad Nacional Mayor de San Marcos, and in accordance with the international requirements of the 3Rs. Fifteen female albino rats (Peruvian National Institute of Health), weighing approximately 200 g each and 8 weeks old, were used. The animals were reared in polycarbonate cages with sawdust bedding; environmental conditions were controlled (22 ± 2 °C and 50 ± 10% relative humidity) with a 12 h light cycle. Feed and drinking water were supplied ad libitum.
Treated animals received a single daily oral administration of the fungicide ipconazole at doses of 1, 5, 10 and 20 mg/kg body weight (b.w.) for 6 consecutive days. In this study, the doses of ipconazole were 1/888, 1/177, 1/88 and 1/44 of the LD50 [25]. Animals in the control and ipconazole-treated groups were deprived of food for 6 h prior to oral administration of ipconazole but were allowed water ad libitum. Doses of ipconazole were dissolved in corn oil for subsequent oral administration at a maximum volume of 0.5 mL/rat. Control animals received only corn oil (vehicle).
Animals were euthanized by decapitation 24 h after the last administration, after which the brains were removed and rinsed with 0.9% (w/v) sodium chloride to remove traces of other tissues. Brain regions (hypothalamus, cerebral cortex, striatum and hippocampus) were dissected out cold (4 °C) and immediately frozen at −80 °C for further analysis.

2.3. Reactive Oxygen Species (ROS) Generation Assay

A total of 10 mg of each brain region was homogenized in a buffer containing 50 mM HEPES, 320 mM sucrose and protease inhibitors. Immediately, a total of 15 µL of homogenate (equivalent to 1 mg of brain region) was added to 80 µM (final concentration) of DCFH-DA (diluted in DMSO) in phosphate-buffered saline (PBS). The reaction was carried out in black 96-well plates at an incubation temperature of 37 °C for 30 min [26,27]. ROS production was recorded on a FLX800 fluorometer (BioTek, Winooski, VT, USA) with an excitation/emission wavelength (485 nm/528 nm).

2.4. Determination of Malondialdehyde (MDA) Levels

In total, ≥10 mg of brain region was homogenized with lysis buffer containing sodium duodecyl sulphate (SDS). The homogenate was centrifuged at 13,000× g for 15 min at 4 °C. Then, 250 μL of the supernatant was vigorously mixed with 250 µL of thiobarbituric acid (0.07%) dissolved in sodium sulphate solution [28]. The mixture was incubated at 95 °C for 60 min and read spectrophotometrically at 532 nm (Agilent Technologies, Santa Clara, CA, USA).

2.5. Catalase Activity Assay

For this assay, the catalase colorimetric activity assay kit (Invitrogen, Thermo Fisher Scientific, MA, USA) was used according to the manufacturer’s guidelines. Briefly, ≥20 mg of brain region was homogenized with the kit-supplemented buffer at 4 °C, then the homogenate was centrifuged at 10,000× g for 15 min at 4 °C, and the supernatant was immediately processed. In a 96-well plate, 25 µL of the sample was mixed with 25 µL of hydrogen peroxide reagent for 30 min at room temperature, then 25 µL of horseradish peroxidase was added and incubated for 15 min at room temperature. Spectrophotometric reading was performed at 560 nm (Agilent Technologies, CA, USA), and optical density values were calculated from the standard curve fit to obtain the catalase activity in U/mL/mg tissue.

2.6. qPCR Analysis of Cell Death and Inflammasome Complex Biomarkers

Molecular expression of genes related to cell death and the inflammasome complex was performed using 3 kits: RNA extraction, retrotranscription (RT-PCR) and molecular amplification (qPCR). (1) Total RNA extraction was performed from ≥15 mg of brain region following the manufacturer’s specifications (NucleoSpin RNA Plus Kit, MACHEREY-NAGEL, Düren, Germany), and the concentration was measured in a nanospectrophotometer (Microdigital, Seoul, Republic of Korea) obtaining A260/A280 ratios between 1.9 and 2.1. (2) RT-PCR was performed on 400 ng of total RNA using the cDNA synthesis kit (PCRBiosystems, Wayne, PA, USA) under thermocycling parameters of 42 °C for 30 min and 85 °C for 10 min. (3) Gene amplification and quantification was performed using MasterMix ICgreen (Nippon Genetics, Duren, Germany) according to supplier specifications, and the thermocycling protocol used was 95 °C for 2 min, 40 cycles of 5 s at 95 °C and 30 s at 60 °C. This was performed with Bio-Rad CFX (BioRad, Hercules, CA, USA) [29]. The primers used in this study were specific for cell death (AKT1, APAF1, BNIP3, CASP3 and BAX) and the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) biomarkers (Supplementary Material S1).

2.7. Statistical Analysis

Data were analyzed using GraphPad Prism 8 statistical software(GRAPHPAD SOFTWARE, BOSTON, MA, USA). Results are presented as the percentage (%) or fold change compared to the control and expressed as the mean ± SEM per group. Significant differences between control and treated groups were determined using one-way ANOVA followed by Tukey’s post hoc test. Results were considered significant at * p < 0.05, ** p < 0.01 or *** p < 0.001.

3. Results

In the present study, we evaluated the effect of ipconazole at doses of 1, 5, 10 and 20 mg/kg b.w. during 6 days of treatment on the hypothalamus, cerebral cortex, striatum and hippocampus brain regions of albino rats. Briefly, we observed that ipconazole produced a deleterious effect in the rat brain, increasing the levels of ROS, MDA and genes related to cell death and the inflammasome complex; in addition, the levels of catalase enzyme activity were reduced by ipconazole. These results are described in detail below.

3.1. ROS Production

Oxidative stress can trigger multiple deleterious effects in cells, including damage to biomolecules, altered cellular responses, inflammatory processes and even cell death. In the present study, we evaluated ROS production induced by the fungicide ipconazole (1, 5, 10 and 20 mg/kg b.w.) in four regions of rat brains. Ipconazole significantly (*** p ≤ 0.001) increased ROS levels in a dose-dependent manner (5, 10 and 20 mg/kg b.w.) in the hypothalamus (by 58, 75 and 98%, respectively) (Figure 1A), cerebral cortex (by 10, 36 and 106%, respectively) (Figure 1B), striatum (by 21, 45 and 55%, respectively) (Figure 1C) and hippocampus (by 50, 56 and 71%, respectively) (Figure 1D).

3.2. MDA Levels

Lipid peroxidation is directly associated with elevated ROS levels, as observed in our study. A 2.5-fold increase (*** p ≤ 0.001) in MDA levels was observed in the hypothalamus (Figure 2A) and striatum (Figure 2C) with ipconazole at a dose of 20 mg/kg b.w. Similarly, MDA levels increased dose-dependently with ipconazole concentrations of 5, 10 and 20 mg/kg b.w. in the cerebral cortex (1.3-, 1.5- and 1.5-fold, respectively) (Figure 2B) and hippocampus (1.6-, 2- and 3-fold, respectively) (Figure 2D).

3.3. Catalase Activity

Catalase oxidoreductase enzyme activity was evaluated in the brain regions of albino rats exposed to ipconazole at doses of 1, 5, 10 and 20 mg/kg b.w. for 6 days. A decrease in catalase enzyme activity was observed in all brain regions because of ipconazole exposure. In the hypothalamus (Figure 3A), catalase activity was reduced by 12% (** p ≤ 0.01) at the 20 mg/kg b.w. dose of ipconazole. In the cerebral cortex (Figure 3B), there was a significant (*** p ≤ 0.001) reduction in catalase enzyme activity by 50% (5 mg/kg b.w.), 35% (10 mg/kg b.w.) and 57% (20 mg/kg b.w.). In the striatum (Figure 3C), catalase enzyme activity was significantly decreased by 23% (*** p ≤ 0.001) at 5 mg/kg b.w., 9% (** p ≤ 0.01) at 10 mg/kg b.w. and 7% (*p ≤ 0.05) at 20 mg/kg b.w. Finally, in the hippocampus (Figure 3D), there was a significant reduction (*** p ≤ 0.001) in catalase enzyme activity by 58% at 10 mg/kg b.w. and 23% at 20 mg/kg b.w. of ipconazole.

3.4. Molecular Biomarkers of Cell Death

Increased oxidative stress products, such as ROS and MDA, and a possible decrease in antioxidant activity can trigger cell death. In our study, we evaluated the molecular expression of cell death-related biomarkers in the brain regions of rats exposed to different concentrations of ipconazole. As shown in Figure 4, ipconazole at doses of 10 and 20 mg/kg b.w. produced a significant increase in the molecular biomarkers AKT1 (1.3- and 1.4-fold, respectively), BNIP3 (1.9- and 1.4-fold, respectively) and BAX (1.6- and 1.6-fold, respectively). Additionally, ipconazole at a dose of 20 mg/kg b.w. produced a significant 1.9-fold increase in the biomarker APAF1.
Figure 5 shows that in the cerebral cortex, ipconazole at doses of 5, 10 and 20 mg/kg b.w. increased the expression of the molecular biomarker BAX by 1.6-, 1.4- and 1.7-fold, respectively, in a dose-dependent manner relative to the control. Furthermore, ipconazole at doses of 10 and 20 mg/kg b.w. resulted in a 1.7- and 1.8-fold increase in the biomarker APAF1. At 20 mg/kg b.w., the AKT1 and CASP3 biomarkers increased 1.7- and 1.5-fold, respectively, compared to the control.
In the striatum, ipconazole increased APAF1 molecular expression in a dose-dependent manner by 3.5- (5 mg/kg b.w.), 3.4- (10 mg/kg b.w.) and 3.1-fold (20 mg/kg b.w.), compared to the control. Furthermore, at the highest dose of ipconazole (20 mg/kg b.w.), the molecular expression of AKT1 (1.9-fold), BNIP3 (1.9-fold), CASP3 (4.1-fold) and BAX (2.4-fold) was increased (Figure 6).
In the hippocampus (Figure 7), ipconazole at doses of 5, 10 and 20 mg/kg b.w. increased the expression levels of AKT1 (2.1-, 2.1- and 2.9-fold, respectively) and BAX (1.3-, 1.4- and 1.8-fold, respectively). The highest dose of ipconazole produced increases in the molecular expression of BNIP3 (2.7-fold) and CASP3 (1.7-fold), compared to the control.

3.5. Molecular Biomarkers Related to the Inflammasome Complex

The inflammasome is a cytosolic multiprotein complex that triggers the activation of a strong inflammatory response, and its activation may be strongly related to oxidative stress. In this study, we evaluated the effect of ipconazole on the molecular expression of mediators directly and indirectly related to the formation of the inflammasome complex. In the hypothalamus, ipconazole at a dose of 20 mg/kg b.w. significantly increased the molecular expression of the biomarkers IL6 (1.7-fold), NLRP3 (2-fold) and NFκB (1.6-fold), compared to the control (Figure 8). In the cerebral cortex, the dose of 10 mg/kg b.w. of ipconazole increased the molecular expression of the biomarker CASP1 by 1.5-fold, while the dose of 20 mg/kg b.w. of ipconazole increased the molecular expressions of IL1β, IL6, NLRP3, NFκB and TNFα by 2-, 2.4-, 3.4-, 1.9- and 2-fold, respectively (Figure 9). Similar effects of the fungicide ipconazole (at a dose of 20 mg/kg b.w.) were observed in the striatum (Figure 10) and hippocampus (Figure 11), with significant increases in the expression of IL1β (2.1-fold), NLRP3 (4.5-fold), NFκB (2.1-fold) and TNFα (2.6-fold) (Figure 10) and IL1β (2.5-fold), IL6 (2.2-fold) and NLRP3 (2.6-fold) (Figure 11).

4. Discussion

Several studies have shown that triazole fungicides can be absorbed through the skin, gastrointestinal tract and pulmonary tract and can even easily cross the blood–brain barrier and placental barrier, causing severe damage to the body [30]. In our study, experimental animals were orally exposed to different doses of the fungicide ipconazole to assess its toxicity in brain regions including the hypothalamus, cerebral cortex, striatum and hippocampus.
In the present study, ipconazole significantly increased ROS production in brain regions in a dose-dependent manner at doses of 5, 10 and 20 mg/kg b.w., indicating the oxidative action of this pesticide. Similarly, MDA levels increased with ipconazole at the highest dose in the hypothalamus and striatum, and in a dose-dependent manner in the cerebral cortex and hippocampus. These results demonstrate a close relationship between the high levels of ROS and MDA due to ipconazole exposure. The increase in ROS arises from an imbalance between antioxidant and prooxidant molecules, usually induced by endogenous or exogenous agents, leading to the activation of signaling pathways associated with cell damage or the production of other more dangerous prooxidant molecules such as MDA [31]. ROS are the main effector molecules of oxidative stress, occurring in physiological or pathological states, and are produced in mitochondria and cellular endomembrane where enzymatic reactions and autooxidation of various compounds occur [32]. Many exogenous factors, such as pesticide chemicals, precipitate ROS production, which in turn produces other free radicals or metabolites from lipid peroxidation such as MDA. MDA is formed from the reaction of free radicals and lipids and can alter cell membrane structure, subsequently causing DNA alterations at the cellular level [33]. Polyunsaturated fatty acids are the biomolecules most affected by oxidative stress, leading to lipid peroxidation, the main product of which is MDA, known for its mutagenic and toxic effects [34].
Several in vivo and in vitro studies have shown that pesticides can induce oxidative stress in the nervous system through the production of ROS and MDA, as reported in the present study. In the case of triazole fungicides, we have previously described the oxidative cytotoxic effect (increased ROS production) of ipconazole on SH-SY5Y neuronal cells [18]. Similar results have also been described with other triazoles. For instance, the fungicide epoxiconazole induced an increase of ROS and MDA in rat PC12 cells [35], while the triazoles propiconazole and tebuconazole at high doses induced a significant increase in ROS and MDA in SH-SY5Y cells [36]. Additionally, a mixture of six triazoles (imazalil, flusilazole, fluconazole, tebuconazole, triadimefon and cyproconazole) had a low effect on ROS production in PC12 cells [37]. Furthermore, penconazole increased MDA levels in rat brains [38], and the fungicide difenoconazole augmented ROS levels in carp brains [39].
The effective way to reduce the deleterious effects of cellular oxidative stress is to increase the activity of antioxidant enzymes. In the present study, we evaluated the effect of ipconazole on the activity of the enzyme catalase, which is capable of converting hydrogen peroxide (H2O2) into water and oxygen. In the hypothalamus, only the highest dose of ipconazole resulted in a significant decrease in catalase enzyme activity, while ipconazole dose-dependently decreased catalase activity in the other brain regions studied. Lower catalase activity could lead to an increase in H2O2, which at high concentrations is toxic because it can easily be converted into the superoxide anion (O2•−) and hydroxyl radical (•OH), molecules closely related to oxidative damage and neuronal aging. In addition, brain catalase levels are lower compared to other organs, requiring the action of peroxidases for H2O2 removal [40,41]. Similar effects to those observed in our study have been described for the fungicide penconazole, which decreased catalase enzyme activity in rat brains [38]. This effect was also observed in the nervous system of carp after exposure to difenoconazole [39]. Conversely, the fungicide propiconazole increased catalase activity in zebrafish brains [8], and epoxiconazole increased catalase activity 8-fold in rat F98 glial cells [42].
The results presented indicate that ipconazole could negatively alter the oxidative status in the rat brain by increasing the production of ROS and MDA while decreasing the activity of the enzyme catalase. Elevated levels of free radicals can activate cellular pathways that lead to increased cell damage and even cell death. Increased ROS serves as a cell death-inducing factor when it activates the intrinsic DNA damage apoptosis pathway. These stress signals typically activate proapoptotic proteins such as BAX, BNIP3, APAF1 and CASP3 [42,43,44,45].
The present study demonstrates that the fungicide ipconazole increased the molecular expression of several biomarkers (APAF1, BNIP3, CASP3 and BAX) of cell death in all brain regions studied (hypothalamus, cerebral cortex, striatum and hippocampus). This increase in the expression of cell death biomarkers could be attributed to the elevated levels of ROS and MDA found in this study. Other studies have shown similar results regarding the effect of triazoles. For instance, penconazole up-regulated BAX and CASP3 mRNA in rat brains [46]; ipconazole induced molecular expression of BAX, CASP3, APAF1 and BNIP3 and increased caspase 3/7 enzyme activity in SH-SY5Y cells [18]; and epoxiconazole induced apoptosis in rat PC12 cells [35]. The overexpression of various cell death biomarkers such as APAF1 would be associated with neurodegenerative pathologies related to neuronal death [47] by acting as proapoptotic proteins and producing mitochondrial dysfunction, which is the case of BNIP3 [48]; these neurodegenerative effects were demonstrated in dopaminergic neuronal death following BAX overexpression [49]. Furthermore, caspase-3 overexpression in Alzheimer’s disease confirms the role of the extrinsic pathway in neuronal apoptosis and amyloid-β deposition [50].
ROS are a group of molecules including H2O2, O2•− and •OH, which play roles in maintaining redox homeostasis at physiological levels [51]. However, their excess can lead to deleterious effects by activating inflammatory pathways such as the inflammasome complex associated with apoptosis [52]. The NLRP3 inflammasome complex serves as a cellular stress sensor, as its activation depends on ROS generation [53,54]. Mitochondrial dysfunction, characterized by DNA damage and excessive ROS production, contributes to NLRP3 inflammasome activation. This activation triggers CASP1 activation and the release of the cytokine IL1β in response to cellular damage signals associated with mitochondrial injury [55,56]. It is known that oxidized mitochondrial DNA (OX-mtDNA) can induce NLRP3 inflammasome activation during apoptosis, and that this OX-mtDNA is released from mitochondria due to NFκB-induced mitochondrial dysfunction in the presence of ATP. Subsequently, OX-mtDNA binds to and activates the NLRP3 inflammasome in the cytoplasm [57].
Furthermore, ROS not only directly regulate the inflammasome assembly process but also indirectly regulate inflammasome activity by affecting cytoplasmic proteins [58]. ROS-induced activation of the NFκB pathway not only stimulates NLRP3 inflammasome formation but also directly promotes the expression of TNFα, pro-IL1β, IL6 and other components of the inflammasome complex [59]. Activation or overexpression of the inflammasome complex has been reported in diseases such as Alzheimer’s or Parkinson’s disease. In post mortem studies of brains from Parkinson’s or Alzheimer’s patients, overexpression of IL1β and Casp1 was reported [60]. Fibrillar amyloid-β was also shown to act as a trigger for NLRP3 microglial inflammasome assembly or NFκB response [61,62].
It is plausible that the results of our study are consistent with the above findings, as several biomarkers (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) related to the inflammasome complex showed increased molecular expression in the hypothalamus, cerebral cortex, striatum and hippocampus of rats exposed to the fungicide ipconazole. A similar effect of ipconazole has been reported in SH-SY5Y cells [18].

5. Conclusions

In conclusion, a six-day acute oral exposure to the fungicide ipconazole in rats resulted in increased production of ROS and MDA, accompanied by decreased activity of the antioxidant enzyme catalase. These changes exacerbated oxidative stress across all brain regions studied. Additionally, this oxidative damage likely contributed to the up-regulation of molecular biomarkers associated with cell death (AKT1, APAF1, BNIP3, CASP3 and BAX) and inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFĸB and TNFα) activation. Our findings suggest that ipconazole should be considered an environmental risk factor for the development of nervous system disorders in mammals.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxics12090638/s1, S1: Forward and reverse sequences for genes related to cell death and inflammasome complex biomarkers.

Author Contributions

Conceptualization, L.B.-A., M.R.-G., O.R.-C., A.R. and J.-L.R.; Data curation, B.L.-M.; Formal analysis, C.V., L.I.-R. and J.-L.R.; Funding acquisition, C.V. and M.R.-G.; Investigation, C.V., B.L.-M. and M.R.-G.; Methodology, C.V., L.B.-A. and L.I.-R.; Resources, L.B.-A. and O.R.-C.; Supervision, M.R.-G. and O.R.-C.; Writing—original draft, L.I.-R., A.R. and J.-L.R.; Writing—review and editing, A.R. and J.-L.R. All authors have read and agreed to the published version of the manuscript.

Funding

(1) PE501085041-2023-PROCIENCIA, CONCYTEC-PERU; (2) National University of San Marcos PCONFIGI A23080521.

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Review Board of the Bioethics Committee (CEBA) of the Faculty of Veterinary Medicine, San Marcos University-Lima-Peru, Approval code 2024-14.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Acknowledgments

We are grateful to PPROCIENCIA-CONCYTEC-PERU for funding part of this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Hüesker, F.; Lepenies, R. Why does pesticide pollution in water persist? Environ. Sci. Policy 2022, 128, 185–193. [Google Scholar] [CrossRef]
  2. Zubrod, J.P.; Bundschuh, M.; Arts, G.; Brühl, C.A.; Imfeld, G.; Knäbel, A.; Payraudeau, S.; Rasmussen, J.J.; Rohr, J.; Scharmüller, A.; et al. Fungicides: An overlooked pesticide class? Environ. Sci. Technol. 2019, 53, 3347–3365. [Google Scholar] [CrossRef] [PubMed]
  3. Del Puerto, O.; Gonçalves, N.P.F.; Medana, C.; Prevot, A.B.; Roslev, P. Attenuation of toxicity and occurrence of degradation products of the fungicide tebuconazole after combined vacuum UV and UVC treatment of drinking water. Environ. Sci. Pollut. Res. 2022, 29, 58312–58325. [Google Scholar] [CrossRef] [PubMed]
  4. Roman, D.L.; Voiculescu, D.I.; Filip, M.; Ostafe, V.; Isvoran, A. Effects of triazole fungicides on soil microbiota and on the activities of enzymes found in soil: A review. Agriculture 2021, 11, 893. [Google Scholar] [CrossRef]
  5. Roman, D.L.; Voiculescu, D.I.; Matica, M.A.; Baerle, V.; Filimon, M.N.; Ostafe, V.; Isvoran, A. Assessment of the effects of triticonazole on soil and human health. Molecules 2022, 27, 6554. [Google Scholar] [CrossRef]
  6. Vieira, M.L.; Costa, N.O.; Pereira, M.R.F.; de Fátima Paccola Mesquita, S.; Moreira, E.G.; Gerardin, D.C.C. Chronic exposure to the fungicide propiconazole: Behavioral and reproductive evaluation of F1 and F2 generations of male rats. Toxicology 2017, 389, 85–93. [Google Scholar] [CrossRef]
  7. Sun, G.; Thai, S.F.; Tully, D.B.; Lambert, G.R.; Goetz, A.K.; Wolf, D.C.; Dix, D.J.; Nesnow, S. Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicol Lett. 2005, 155, 277–287. [Google Scholar] [CrossRef]
  8. Valadas, J.; Mocelin, R.; Sachett, A.; Marcon, M.; Zanette, R.A.; Dallegrave, E.; Herrmann, A.P. Propiconazole induces abnormal behavior and oxidative stress in zebrafish. Environ. Sci. Pollut. Res. Int. 2019, 26, 27808–27815. [Google Scholar] [CrossRef]
  9. Teng, M.; Zhao, W.; Chen, X.; Wang, C.; Zhou, L.; Wang, C.; Xu, Y. Parental exposure to propiconazole at environmentally relevant concentrations induces thyroid and metabolism disruption in zebrafish (Danio rerio) offspring: An in vivo, in silico and in vitro study. Ecotoxicol. Environ. Saf. 2022, 242, 113865. [Google Scholar] [CrossRef]
  10. Kwon, H.C.; Sohn, H.; Kim, D.H.; Shin, D.M.; Jeong, C.H.; Chang, Y.H.; Yune, J.H.; Kim, Y.J.; Kim, D.W.; Kim, S.H.; et al. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis. Agric. Food Chem. 2021, 69, 7399–7408. [Google Scholar] [CrossRef]
  11. Chaâbane, M.; Elwej, A.; Ghorbel, I.; Chelly, S.; Mnif, H.; Boudawara, T.; Ellouze Chaabouni, S.; Zeghal, N.; Soudani, N. Penconazole alters redox status, cholinergic function and lung’s histoarchitecture of adult rats: Reversal effect of vitamin E. Biomed. Pharmacother. 2018, 102, 645–652. [Google Scholar] [CrossRef]
  12. El-Shershaby, A.E.M.; Lashein, F.E.M.; Seleem, A.A.; Ahmed, A.A. Developmental neurotoxicity after penconazole exposure at embryo pre- and post-implantation in mice. J. Histotechnol. 2020, 43, 135–146. [Google Scholar] [CrossRef] [PubMed]
  13. Ben Othmène, Y.; Hamdi, H.; Annabi, E.; Amara, I.; Ben Salem, I.; Neffati, F.; Najjar, M.F.; Abid-Essefi, S. Tebuconazole induced cardiotoxicity in male adult rat. Food Chem Toxicol. 2020, 137, 111134. [Google Scholar] [CrossRef]
  14. Chen, X.; Zhu, Q.; Li, X.; Huang, T.; Wang, S.; Wang, Y.; Chen, X.; Lin, Z.; Ge, R.S. Pubertal exposure to tebuconazole increases testosterone production via inhibiting testicular aromatase activity in rats. Chemosphere 2019, 230, 519–526. [Google Scholar] [CrossRef] [PubMed]
  15. Ku, T.; Liu, Y.; Xie, Y.; Hu, J.; Hou, Y.; Tan, X.; Ning, X.; Li, G.; Sang, N. Tebuconazole mediates cognitive impairment via the microbe-gut-brain axis (MGBA) in mice. Environ. Int. 2023, 173, 107821. [Google Scholar] [CrossRef] [PubMed]
  16. Ben Othmène, Y.; Monceaux, K.; Belhadef, A.; Karoui, A.; Ben Salem, I.; Boussabbeh, M.; Abid-Essefi, S.; Lemaire, C. Triazole fungicide tebuconazole induces apoptosis through ROS-mediated endoplasmic reticulum stress pathway. Environ. Toxicol. Pharmacol. 2022, 94, 103919. [Google Scholar] [CrossRef]
  17. Lee, G.; Banik, A.; Eum, J.; Hwang, B.J.; Kwon, S.H.; Kee, Y. Ipconazole Disrupts Mitochondrial Homeostasis and Alters GABAergic Neuronal Development in Zebrafish. Int. J. Mol. Sci. 2022, 24, 496. [Google Scholar] [CrossRef]
  18. Villaorduña, C.; Mendoza-Carlos, M.; Chuyma, M.; Avilés, J.; Avalos-Diaz, A.; Lozano-Reategui, R.; Garcia-Ruiz, J.; Panduro-Tenazoa, N.; Vargas, J.; Moran-Quintanilla, Y. Ipconazole Induces Oxidative Stress, Cell Death, and Proinflammation in SH-SY5Y Cells. Toxics 2023, 11, 566. [Google Scholar] [CrossRef]
  19. Ruiz-Yance, I.; Siguas, J.; Bardales, B.; Robles-Castañeda, I.; Cordova, K.; Ypushima, A.; Estela-Villar, E.; Quintana-Criollo, C.; Estacio, D.; Rodríguez, J.L. Potential Involvement of Oxidative Stress, Apoptosis and Proinflammation in Ipconazole-Induced Cytotoxicity in Human Endothelial-like Cells. Toxics 2023, 11, 839. [Google Scholar] [CrossRef]
  20. Li, M.; Li, T.; Duan, Y.; Yang, Y.; Wu, J.; Zhao, D.; Xiao, X.; Pan, X.; Chen, W.; Wang, J.; et al. Evaluation of Phenamacril and Ipconazole for Control of Rice Bakanae Disease Caused by Fusarium fujikuroi. Plant Dis. 2018, 102, 1234–1239. [Google Scholar] [CrossRef]
  21. Zhang, C.; Imran, M.; Xiao, L.; Hu, Z.; Li, G.; Zhang, F.; Liu, X. Difenoconazole Resistance Shift in Botrytis cinerea From Tomato in China Associated with Inducible Expression of CYP51. Plant Dis. 2021, 105, 400–407. [Google Scholar] [CrossRef]
  22. Penagos-Tabares, F.; Sulyok, M.; Faas, J.; Krska, R.; Khiaosa-Ard, R.; Zebeli, Q. Residues of pesticides and veterinary drugs in diets of dairy cattle from conventional and organic farms in Austria. Environ. Pollut. 2023, 316 Pt 2, 120626. [Google Scholar] [CrossRef] [PubMed]
  23. European Food Safety Authority (EFSA). Statement concerning the review of the approval of the active substance ipconazole. EFSA J. Eur. Food Saf. Auth. 2022, 20, e07133. [Google Scholar]
  24. EUR-Lex. COMMISSION IMPLEMENTING REGULATION (EU) 2023/939. Official Journal of the European Union. 2023. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX%3A32023R0939 (accessed on 11 May 2023).
  25. USEPA. Pesticide Fact Sheet IPCONAZZOLE, Conditional Registration. United States Environmental Protection and Agency. 2004. Available online: https://echa.europa.eu/documents/10162/2f059316-df28-80f7-cd3f-a1a1cfa73680 (accessed on 11 May 2023).
  26. Keston, A.; Brandt, R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal. Biochem. 1965, 11, 1–5. [Google Scholar] [CrossRef]
  27. LeBel, C.; Ali, S.; McKee, M.; Bondy, S. Organometal-induced increases in oxygen radical species: The potential of 2,7-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 1990, 104, 17–24. [Google Scholar] [CrossRef] [PubMed]
  28. Dasgupta, A.; Klein, K. Methods for measuring oxidative stress in the laboratory. In Antioxidants in Food, Vitamins and Supplements; Academic Press: Cambridge, MA, USA, 2014; pp. 19–40. [Google Scholar]
  29. Rodríguez, J.L.; Berrios, P.; Clavo, Z.M.; Marin-Bravo, M.; Inostroza-Ruiz, L.; Ramos-Gonzalez, M.; Quispe-Solano, M.; Fernández-Alfonso, M.S.; Palomino, O.; Goya, L. Chemical Characterization, Antioxidant Capacity and Anti-Oxidative Stress Potential of South American Fabaceae Desmodium tortuosum. Nutrients 2023, 15, 746. [Google Scholar] [CrossRef]
  30. Chambers, J.E.; Greim, H.; Kendall, R.J.; Segner, H.; Sharpe, R.M.; Van Der Kraak, G. Human and ecological risk assessment of a crop protection chemical: A case study with the azole fungicide epoxiconazole. Crit. Rev. Toxicol. 2014, 44, 176–210. [Google Scholar] [CrossRef]
  31. Jomova, K.; Raptova, R.; Alomar, S.Y.; Alwasel, S.H.; Nepovimova, E.; Kuca, K.; Valko, M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Arch. Toxicol. 2023, 97, 2499–2574. [Google Scholar] [CrossRef]
  32. Rauf, A.; Khalil, A.A.; Awadallah, S.; Khan, S.A.; Abu-Izneid, T.; Kamran, M.; Hemeg, H.A.; Mubarak, M.S.; Khalid, A.; Wilairatana, P. Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors-A review. Food. Sci. Nutr. 2023, 12, 675–693. [Google Scholar] [CrossRef]
  33. Juan, C.A.; Pérez de la Lastra, J.M.; Plou, F.J.; Pérez-Lebeña, E. The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int. J. Mol. Sci. 2021, 22, 4642. [Google Scholar] [CrossRef]
  34. Mortensen, M.S.; Ruiz, J.; Watts, J.L. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells. 2023, 12, 804. [Google Scholar] [CrossRef]
  35. Hamdi, H.; Rjiba-Touati, K.; Ayed-Boussema, I.; M’nassri, A.; Chaabani, H.; Rich, S.; Abid-Essefi, S. Epoxiconazole caused oxidative stress related DNA damage and apoptosis in PC12 rat Pheochromocytoma. Neurotoxicology 2022, 89, 184–190. [Google Scholar] [CrossRef]
  36. Sanchez, C.L.; Souders, C.L., 2nd; Pena-Delgado, C.J.; Nguyen, K.T.; Kroyter, N.; Ahmadie, N.E.; Aristizabal-Henao, J.J.; Bowden, J.A.; Martyniuk, C.J. Neurotoxicity assessment of triazole fungicides on mitochondrial oxidative respiration and lipids in differentiated human SH-SY5Y neuroblastoma cells. Neurotoxicology 2020, 80, 76–86. [Google Scholar] [CrossRef] [PubMed]
  37. Heusinkveld, H.J.; Molendijk, J.; van den Berg, M.; Westerink, R.H. Azole fungicides disturb intracellular Ca2+ in an additive manner in dopaminergic PC12 cells. Toxicol. Sci. Off. J. Soc. Toxicol. 2013, 134, 374–381. [Google Scholar] [CrossRef] [PubMed]
  38. Chaâbane, M.; Ghorbel, I.; Elwej, A.; Mnif, H.; Boudawara, T.; Chaâbouni, S.E.; Zeghal, N.; Soudani, N. Penconazole alters redox status, cholinergic function, and membrane-bound ATPases in the cerebrum and cerebellum of adult rats. Hum. Exp. Toxicol. 2017, 36, 854–866. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, F.; Wang, Y.; Chen, L.; Bello, B.K.; Zhang, T.; Yang, H.; Li, X.; Pan, E.; Feng, H.; Dong, J. Difenoconazole disrupts the blood-brain barrier and results in neurotoxicity in carp by inhibiting the Nrf2 pathway mediated ROS accumulation. Ecotoxicol. Environ. Saf. 2022, 244, 114081. [Google Scholar] [CrossRef] [PubMed]
  40. Beckman, K.B.; Ames, B.N. The free radical theory of aging matures. Physiol Rev. 1998, 78, 547–581. [Google Scholar] [CrossRef]
  41. Kregel, K.C.; Zhang, H.J. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R18–R36. [Google Scholar] [CrossRef]
  42. Hamdi, H.; Abid-Essefi, S.; Eyer, J. Neuroprotective effects of Myricetin on Epoxiconazole-induced toxicity in F98 cells. Free Radic. Biol. Med. 2021, 164, 154–163. [Google Scholar] [CrossRef]
  43. Yan, N.; Shi, Y. Mechanisms of apoptosis through structural biology. Annu. Rev. Cell Dev. Biol. 2005, 21, 35–56. [Google Scholar] [CrossRef]
  44. Hu, Q.; Wu, D.; Chen, W.; Yan, Z.; Yan, C.; He, T.; Liang, Q.; Shi, Y. Molecular determinants of caspase-9 activation by the Apaf-1 apoptosome. Proc. Natl. Acad. Sci. USA 2014, 111, 16254–16261. [Google Scholar] [CrossRef] [PubMed]
  45. Riedl, S.J.; Salvesen, G.S. The apoptosome: Signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007, 8, 405–413. [Google Scholar]
  46. Morgan, A.M.; Hassanen, E.I.; Ogaly, H.A.; Al Dulmani, S.A.; Al-Zahrani, F.A.M.; Galal, M.K.; Kamel, S.; Rashad, M.M.; Ibrahim, M.A.; Hussien, A.M. The ameliorative effect of N-acetylcysteine against penconazole induced neurodegenerative and neuroinflammatory disorders in rats. J. Biochem. Mol. Toxicol. 2021, 35, e22884. [Google Scholar] [CrossRef] [PubMed]
  47. Shakeri, R.; Kheirollahi, A.; Davoodi, J. Contribution of Apaf-1 to the pathogenesis of cancer and neurodegenerative diseases. Biochimie 2021, 190, 91–110. [Google Scholar] [CrossRef] [PubMed]
  48. Schmid, E.T.; Pyo, J.H.; Walker, D.W. Neuronal induction of BNIP3-mediated mitophagy slows systemic aging in Drosophila. Nat. Aging 2022, 2, 494–507. [Google Scholar] [CrossRef] [PubMed]
  49. Vila, M.; Jackson-Lewis, V.; Vukosavic, S.; Djaldetti, R.; Liberatore, G.; Offen, D.; Korsmeyer, S.J.; Przedborski, S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2001, 98, 2837–2842. [Google Scholar] [CrossRef]
  50. Wójcik, P.; Jastrzębski, M.K.; Zięba, A.; Matosiuk, D.; Kaczor, A.A. Caspases in Alzheimer’s Disease: Mechanism of Activation, Role, and Potential Treatment. Mol. Neurobiol. 2024, 61, 4834–4853. [Google Scholar] [CrossRef]
  51. Ray, P.D.; Huang, B.W.; Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24, 981–990. [Google Scholar] [CrossRef]
  52. Tschopp, J.; Schroder, K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 2010, 10, 210–215. [Google Scholar] [CrossRef]
  53. Petrilli, V.; Papin, S.; Dostert, C.; Mayor, A.; Martinon, F.; Tschopp, J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007, 14, 1583–1589. [Google Scholar] [CrossRef]
  54. Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11, 136–140. [Google Scholar] [CrossRef]
  55. Zhou, R.; Yazdi, A.S.; Menu, P.; Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469, 221–225. [Google Scholar] [CrossRef]
  56. Wu, X.; Gong, L.; Xie, L.; Gu, W.; Wang, X.; Liu, Z.; Li, S. NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea. Front. Immunol. 2021, 12, 628168. [Google Scholar] [CrossRef] [PubMed]
  57. Shimada, K.; Crother, T.R.; Karlin, J.; Dagvadorj, J.; Chiba, N.; Chen, S.; Ramanujan, V.K.; Wolf, A.J.; Vergnes, L.; Ojcius, D.M.; et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36, 401–414. [Google Scholar] [CrossRef] [PubMed]
  58. Liang, H.; Zhang, F.; Wang, W.; Zhao, W.; Zhou, J.; Feng, Y.; Wu, J.; Li, M.; Bai, X.; Zeng, Z.; et al. Heat Shock Transcription Factor 2 Promotes Mitophagy of Intestinal Epithelial Cells Through PARL/PINK1/Parkin Pathway in Ulcerative Colitis. Front. Pharmacol. 2022, 13, 893426. [Google Scholar] [CrossRef] [PubMed]
  59. Pang, Y.; Wu, D.; Ma, Y.; Cao, Y.; Liu, Q.; Tang, M.; Pu, Y.; Zhang, T. Reactive oxygen species trigger NF-κB-mediated NLRP3 inflammasome activation involvement in low-dose CdTe QDs exposure-induced hepatotoxicity. Redox Biol. 2021, 47, 102157. [Google Scholar] [CrossRef] [PubMed]
  60. Mogi, M.; Harada, M.; Narabayashi, H.; Inagaki, H.; Minami, M.; Nagatsu, T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson’s disease. Neurosci. Lett. 1996, 211, 13–16. [Google Scholar] [CrossRef]
  61. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9, 857–865. [Google Scholar] [CrossRef]
  62. Singh, J.; Habean, M.L.; Panicker, N. Inflammasome assembly in neurodegenerative diseases. Trends Neurosci. 2023, 46, 814–831. [Google Scholar] [CrossRef]
Toxics 12 00638 g001
Figure 1. ROS production was measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bar) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. *** p ≤ 0.001 indicates significant differences between the treatments versus the control group.
Figure 1. ROS production was measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bar) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. *** p ≤ 0.001 indicates significant differences between the treatments versus the control group.
Toxics 12 00638 g001
Toxics 12 00638 g002
Figure 2. MDA levels were measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate significant differences between the treatments versus the control group.
Figure 2. MDA levels were measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate significant differences between the treatments versus the control group.
Toxics 12 00638 g002
Toxics 12 00638 g003
Figure 3. Catalase activity was measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate significant differences between the treatments versus the control group.
Figure 3. Catalase activity was measured in the (A) hypothalamus, (B) cerebral cortex, (C) striatum and (D) hippocampus of rat brains. Results are presented as a percentage of the control (mean ± SEM) based on four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate significant differences between the treatments versus the control group.
Toxics 12 00638 g003
Toxics 12 00638 g004
Figure 4. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat hypothalamus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Figure 4. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat hypothalamus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g004
Toxics 12 00638 g005
Figure 5. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat cerebral cortex. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Figure 5. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat cerebral cortex. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g005
Toxics 12 00638 g006
Figure 6. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat striatum. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Figure 6. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat striatum. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g006
Toxics 12 00638 g007
Figure 7. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat hippocampus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Figure 7. Real-time molecular expression of cell death biomarkers (AKT1, APAF1, BNIP3, CASP3 and BAX) in the rat hippocampus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g007
Toxics 12 00638 g008
Figure 8. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat hypothalamus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 indicates the significance between the treatments versus the control group.
Figure 8. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat hypothalamus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 indicates the significance between the treatments versus the control group.
Toxics 12 00638 g008
Toxics 12 00638 g009
Figure 9. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat cerebral cortex. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Figure 9. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat cerebral cortex. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g009
Toxics 12 00638 g010
Figure 10. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat striatum. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Figure 10. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat striatum. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g010
Toxics 12 00638 g011
Figure 11. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat hippocampus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Figure 11. Real-time molecular expression of biomarkers related to the inflammasome complex (CASP1, IL1β, IL6, NLRP3, NFκB and TNFα) in the rat hippocampus. Results are presented as mean ± SEM of four replicates per treatment. The significance between the treatments (green bars) and the control group (black bar) was determined by one-way ANOVA using Tukey’s post hoc test. * p ≤ 0.05 and ** p ≤ 0.01 indicate the significance between the treatments versus the control group.
Toxics 12 00638 g011
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Villaorduña, C.; Barrios-Arpi, L.; Lira-Mejía, B.; Ramos-Gonzalez, M.; Ramos-Coaguila, O.; Inostroza-Ruiz, L.; Romero, A.; Rodríguez, J.-L. The Fungicide Ipconazole Can Activate Mediators of Cellular Damage in Rat Brain Regions. Toxics 2024, 12, 638. https://doi.org/10.3390/toxics12090638

AMA Style

Villaorduña C, Barrios-Arpi L, Lira-Mejía B, Ramos-Gonzalez M, Ramos-Coaguila O, Inostroza-Ruiz L, Romero A, Rodríguez J-L. The Fungicide Ipconazole Can Activate Mediators of Cellular Damage in Rat Brain Regions. Toxics. 2024; 12(9):638. https://doi.org/10.3390/toxics12090638

Chicago/Turabian Style

Villaorduña, Carlos, Luis Barrios-Arpi, Boris Lira-Mejía, Mariella Ramos-Gonzalez, Olger Ramos-Coaguila, Luis Inostroza-Ruiz, Alejandro Romero, and José-Luis Rodríguez. 2024. "The Fungicide Ipconazole Can Activate Mediators of Cellular Damage in Rat Brain Regions" Toxics 12, no. 9: 638. https://doi.org/10.3390/toxics12090638

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop